182 related articles for article (PubMed ID: 18158969)
1. Acute renal failure after nonmyeloablative stem cell transplantation in adults.
Kersting S; Dorp SV; Theobald M; Verdonck LF
Biol Blood Marrow Transplant; 2008 Jan; 14(1):125-31. PubMed ID: 18158969
[TBL] [Abstract][Full Text] [Related]
2. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia.
Liu H; Ding JH; Liu BC; Zhao G; Chen BA
Am J Nephrol; 2007; 27(4):336-41. PubMed ID: 17519537
[TBL] [Abstract][Full Text] [Related]
3. Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival.
Kersting S; Koomans HA; Hené RJ; Verdonck LF
Bone Marrow Transplant; 2007 Mar; 39(6):359-65. PubMed ID: 17342159
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease after nonmyeloablative stem cell transplantation in adults.
Kersting S; Verdonck LF
Biol Blood Marrow Transplant; 2008 Apr; 14(4):403-8. PubMed ID: 18342782
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
Kersting S; Hené RJ; Koomans HA; Verdonck LF
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
[TBL] [Abstract][Full Text] [Related]
7. Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Willems E; Humblet-Baron S; Dengis O; Seidel L; Beguin Y; Baron F
Bone Marrow Transplant; 2010 Sep; 45(9):1442-8. PubMed ID: 20062090
[TBL] [Abstract][Full Text] [Related]
8. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
9. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
[TBL] [Abstract][Full Text] [Related]
10. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT.
Liu H; Li YF; Liu BC; Ding JH; Chen BA; Xu WL; Qian J
Bone Marrow Transplant; 2010 Jan; 45(1):153-8. PubMed ID: 19430501
[TBL] [Abstract][Full Text] [Related]
15. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
16. Acute renal failure after myeloablative allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and relationship with the quantity of transplanted cells.
Tokgoz B; Kocyigit I; Polat G; Eser B; Unal A; Kaynar L; Sipahioglu MH; Oymak O; Utas C; Cetin M
Ren Fail; 2010 Jun; 32(5):547-54. PubMed ID: 20486836
[TBL] [Abstract][Full Text] [Related]
17. Frequency and outcomes of acute renal failure following thoracic aortic stent-graft placement.
Eggebrecht H; Breuckmann F; Martini S; Baumgart D; Herold U; Kienbaum P; Peters J; Jakob H; Erbel R; Mehta RH
Am J Cardiol; 2006 Aug; 98(4):458-63. PubMed ID: 16893697
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on acute kidney injury after myeloablative allogeneic hematopoietic cell transplantation].
Bao YS; Jiang EL; Wang M; Huang Y; Wei JL; Yang DL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):401-4. PubMed ID: 19031744
[TBL] [Abstract][Full Text] [Related]
19. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
Jabbour E; Rondon G; Anderlini P; Giralt SA; Couriel DR; Champlin RE; Khouri IF
Bone Marrow Transplant; 2007 Sep; 40(5):431-5. PubMed ID: 17603511
[TBL] [Abstract][Full Text] [Related]
20. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]